1 / 8

Immunodiagnostics : Market Performance in Upcoming Years based on Market Share, Size, Supply Volume and Key Regions

The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets. The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities. Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.<br>

srushtih123
Download Presentation

Immunodiagnostics : Market Performance in Upcoming Years based on Market Share, Size, Supply Volume and Key Regions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Immunodiagnostics Market to Reach $17,836 Million, Globally, by 2022 Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. Immunodiagnostics Market “Enzyme-Linked Immunosorbent Assay (ELISA) is highly preferred technology due to its minimal invasive nature and is designated as ‐˜gold standard of clinical immunodiagnostics‐™ modality for diagnosing various diseases. Despite numerous advancement in the immunodiagnostics field, ELISA will maintain lead due to its high precision, sensitivity, specificity, and throughput as compared to others at economical cost.”

  3. Immunodiagnostics Market Overview Global Immunodiagnostics Market would reach $17,836 Million by 2022, growing at a CAGR of 7.3% from 2016 to 2022, accordingly new report published by Allied Market Research. Reagents and consumables is expected to dominate the world immunodiagnostics market throughout the forecast period. North America would continue to lead during the forecast period, accounting for more than one-third share of the world immunodiagnostics market in 2015. Access Full Summary at : https://www.alliedmarketresearch.com/immunodiagnostics-market Rise in incidence of infectious diseasesone of the most common disease burden globally mainly drives the market. Growth in baby boomer generation with high-risk of targeted diseases and increase in adoption of next generation immunodiagnostics platform propels the market growth.

  4. Immunodiagnostics Market Dynamics : The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases across the world owing to the growth in aged population and changes in demographics & lifestyle are the major factors to drive the growth of the immunodiagnostics market. In addition, technological advancement in diagnosis kits, assays and analyzers and increase in awareness of the preventive health measures among the patients and medical professionals further stimulate the demand for immunodiagnostics products thus boosting the growth. However, numerous factors are expected to restrain the market development. The impact of the drivers is estimated to be higher than the restraints. Moreover, an increase in effect of the drivers and the restraints is anticipated to reveal new market opportunities for key players manufacturing immunodiagnostics products especially the kits and assays.

  5. Immunodiagnostics has various other end users such as contract research organizations (CROs), blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical services and centers. Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc. are the key players that operate in the global immunodiagnostics market. Other players in the value chain include Arkray, Inc., Alere, Inc., Merck Millipore, Becton, Dickinson and Company, Biomerieux SA, Medicaroid Corporation, Qiagen NV, Affimetrix, ImmunoDX, Meridian Bioscience and others Immunodiagnostics Market, Snapshot

  6. Immunodiagnostics Market Key Benefits • The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets. • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities. • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions. • Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players. • Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.

  7. Immunodiagnostics Market North America Europe Asia-Pacific LAMEA

  8. Immunodiagnostics Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/1763 Follow Us On

More Related